J Capellades

29PUBLICATIONS
266CO-AUTHORS
Predictive and prognostic markersMolecular targetsSensory processes, perception and performanceCancer therapy (excl. chemotherapy and radiation therapy)Semi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 02, 2026
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

|Dec 04, 2025
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.

María Ángeles Vaz-Salgado, Sonia Del Barco, Juan Manuel Sepúlveda

|Jul 08, 2025
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge.

Maximilian Zenk, Ujjwal Baid, Sarthak Pati

|Feb 13, 2025
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Ana Maria Muñoz-Mármol, Bárbara Meléndez, Ainhoa Hernandez

|Mar 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.

Patrick Roth, Thierry Gorlia, Jaap C Reijneveld

|Jan 11, 2024
Unlocking Bevacizumab's Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients.

María Del Mar Álvarez-Torres, Carmen Balaña, Elies Fuster-García

Pageof 5

Frequent Collaborators

6 joint publications

Wolfgang Wick

5 joint publications

Michael Weller

5 joint publications

Martin van den Bent

4 joint publications

Marion Smits